Security
Medgenics, Inc. Warrants Expiring 02/13/2018 · MDGWW
MDGWWOTCWarrantHistorical · closed Feb 14, 2018CIK 1138776Updated Nov 16, 2026
Name history
Aevi Genomic Medicine, Inc. · through Feb 7, 2020MEDGENICS, INC. · through Dec 12, 2016MEDGENICS INC · through Apr 25, 2006
MDGWW price & chart
Historical security
This listing closed Feb 14, 2018. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2018 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2019 | Q3 2018 | Q3 2017 | Q2 2019 | Q2 2018 | Q2 2017 | Q1 2019 | Q1 2018 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 2,796,000Source | 20,187,000Source | 16,949,000Source | 4,021,000Source | 20,233,000Source | 22,740,000Source | 7,624,000Source | 27,434,000Source | 12,277,000Source | 34,761,000Source | 40,561,000Source | 54,258,000Source |
| Property, Plant and Equipment, NetUSD | 1,000Source | 36,000Source | 97,000Source | 1,000Source | 53,000Source | 297,000Source | 4,000Source | 69,000Source | 20,000Source | 85,000Source | 377,000Source | 424,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,381,000Source | 19,602,000Source | 14,960,000Source | 3,437,000Source | 19,151,000Source | 21,357,000Source | 6,948,000Source | 26,520,000Source | 12,076,000Source | 33,729,000Source | 39,838,000Source | 53,064,000Source |
| Assets, CurrentUSD | 2,784,000Source | 20,140,000Source | 15,914,000Source | 4,009,000Source | 20,006,000Source | 22,432,000Source | 7,598,000Source | 27,321,000Source | 12,246,000Source | 34,622,000Source | 40,173,000Source | 53,811,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 403,000Source | 538,000Source | 954,000Source | 572,000Source | 855,000Source | 1,075,000Source | 650,000Source | 801,000Source | 170,000Source | 893,000Source | 335,000Source | 747,000Source |
| Other Assets, NoncurrentUSD | — | 0Source | 927,000Source | — | 163,000Source | — | — | 33,000Source | 0Source | 43,000Source | — | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 6,253,000Source | 6,435,000Source | 6,857,000Source | 3,689,000Source | 4,943,000Source | 4,917,000Source | 3,903,000Source | 4,739,000Source | 4,345,000Source | 4,140,000Source | 5,583,000Source | 3,908,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 7,000Source | 6,000Source | 4,000Source | 7,000Source | 6,000Source | 4,000Source | 7,000Source | 6,000Source | 7,000Source | 6,000Source | 4,000Source | 4,000Source |
| Retained Earnings (Accumulated Deficit)USD | -258,279,000Source | -239,127,000Source | -207,819,000Source | -254,237,000Source | -231,878,000Source | -199,214,000Source | -250,592,000Source | -223,687,000Source | -245,753,000Source | -214,978,000Source | -180,034,000Source | -138,130,000Source |
| Stockholders' Equity Attributable to ParentUSD | -3,457,000Source | 13,752,000Source | 10,092,000Source | 332,000Source | 15,290,000Source | 17,823,000Source | 3,721,000Source | 22,695,000Source | 7,932,000Source | 30,621,000Source | 34,978,000Source | 50,350,000Source |
| Additional Paid in Capital, Common StockUSD | 254,815,000Source | 252,873,000Source | 217,907,000Source | 254,562,000Source | 247,162,000Source | 217,033,000Source | 254,306,000Source | 246,376,000Source | 253,678,000Source | 245,593,000Source | 215,008,000Source | 188,476,000Source |
| Liabilities and EquityUSD | 2,796,000Source | 20,187,000Source | 16,949,000Source | 4,021,000Source | 20,233,000Source | 22,740,000Source | 7,624,000Source | 27,434,000Source | 12,277,000Source | 34,761,000Source | 40,561,000Source | 54,258,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 4,253,000Source | 6,435,000Source | 6,857,000Source | 3,689,000Source | 4,943,000Source | 4,917,000Source | 3,903,000Source | 4,739,000Source | 4,345,000Source | 4,140,000Source | 5,583,000Source | 3,908,000Source |
| Operating Lease, Right-of-Use Asset | — | — | — | — | — | — | —Source | — | — | — | — | — |
| Operating Lease, Liability, Current | — | — | — | — | — | — | —Source | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2018 | Q4 2017 | Q3 2019 | Q3 2018 | Q2 2019 | Q2 2018 | Q1 2019 | Q1 2018 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 253,000Source | 750,000Source | 256,000Source | 786,000Source | 628,000Source | 749,000Source | 3,090,000Source | 3,368,000Source | 6,788,000Source | 9,188,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -5,128,000Source | -7,243,000Source | -26,649,000Source | -33,246,000Source | — | — |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 0Source | 0Source | 0Source | 148,000Source | — | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 0Source | 0Source | 0Source | 4,000Source | 221,000Source | 187,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 0Source | 34,000Source | 4,996,000Source | 26,989,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 9,188,000Source |
| DepreciationUSD | — | — | — | — | — | — | 16,000Source | 16,000Source | 65,000Source | 112,000Source | 268,000Source | 240,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | — | — | 0Source | -32,000Source | 0Source | -18,000Source |
| General and Administrative ExpenseUSD | — | — | 1,543,000Source | 2,174,000Source | 1,415,000Source | 2,504,000Source | 1,685,000Source | 2,174,000Source | 8,663,000Source | 9,524,000Source | 13,523,000Source | 12,954,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 16,000Source | 17,000Source |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | — | 207,000Source | 22,000Source | 10,000Source | 1,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -4,042,000Source | -7,249,000Source | -3,645,000Source | -8,191,000Source | -4,839,000Source | -8,709,000Source | -30,775,000Source | -34,714,000Source | -41,904,000Source | -37,992,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | 41,904,000Source | 37,992,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Nonoperating Income (Expense) | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2018 | Q4 2017 | Q3 2019 | Q3 2018 | Q2 2019 | Q2 2018 | Q1 2019 | Q1 2018 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -4,042,000Source | -7,299,000Source | -3,649,000Source | -8,251,000Source | -4,854,000Source | -8,735,000Source | -30,962,000Source | -34,700,000Source | -41,879,000Source | -36,568,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -30,775,000Source | -34,714,000Source | -41,888,000Source | -37,975,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 16,000Source | 17,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -4,042,000Source | -7,249,000Source | -3,645,000Source | -8,191,000Source | -4,839,000Source | -8,709,000Source | -30,775,000Source | -34,714,000Source | -41,904,000Source | -37,992,000Source |
| Earnings Per Share, BasicUSD per share | — | — | — | — | — | — | — | — | -0.5Source | -0.83Source | 1.19Source | -1.42Source |
| Earnings Per Share, DilutedUSD per share | — | — | — | — | — | — | — | — | -0.5Source | -0.83Source | 1.19Source | -1.45Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 64,766,882Source | 62,019,780Source | 64,766,882Source | 59,338,255Source | 64,766,882Source | 59,334,821Source | 61,381,611Source | 41,675,814Source | 35,161,823Source | 26,783,623Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | — | — | — | — | — | — | 61,381,611Source | 41,675,814Source | 35,161,823Source | 26,846,270Source |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 1,543,000Source | 2,174,000Source | 1,415,000Source | 2,504,000Source | 1,685,000Source | 2,174,000Source | 8,663,000Source | 9,524,000Source | 13,523,000Source | 12,954,000Source |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | — | 207,000Source | 22,000Source | 10,000Source | 1,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | 41,904,000Source | 37,992,000Source |
| Research and Development ExpenseUSD | — | — | 2,499,000Source | 5,125,000Source | — | — | 1,331,000Source | 2,588,000Source | 7,111,000Source | 25,176,000Source | 28,356,000Source | 15,444,000Source |
| Other Nonoperating Income (Expense) | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |